Copyright
©The Author(s) 2020.
World J Gastroenterol. Dec 14, 2020; 26(46): 7352-7366
Published online Dec 14, 2020. doi: 10.3748/wjg.v26.i46.7352
Published online Dec 14, 2020. doi: 10.3748/wjg.v26.i46.7352
Variable | UC patients, n = 100 | HC, n = 56 | P value |
Age [mean (SD), yr] | 45.5 (14.2) | 45.8 (10.0) | 0.8731 |
Sex (female: male) | 57:43 | 32:24 | 0.9862 |
Smoker, n (%) | 45 (45.0) | 21 (37.5) | 0.3632 |
BMI [mean (SD), kg/m2] | 21.2 (3.4) | 20.4 (2.1) | 0.1011 |
25 (OH) D [mean (SD), nmol/L] | 13.7 (2.8) | 16.2 (2.5) | < 0.0011 |
Disease Location, n (%) | |||
Ulcerative proctitis (E1) | 8 (8.0) | - | - |
Left-sided colitis (E2) | 54 (54.0) | - | - |
Extensive colitis (E3) | 38 (38.0) | - | - |
Severity of UC, n (%) | |||
Mild | 29 (29.0) | - | - |
Moderate | 32 (32.0) | - | - |
Severe | 39 (39.0) | - | - |
Current medications, n (%) | |||
SASP/5-ASA | 80 (80.0) | - | - |
Immunosuppressants | 2 (2.0) | - | - |
Steroids | 31 (31.0) | - | - |
Biologics | 4 (4.0) | - | - |
Others | 22 (22.0) | - | - |
Duration of disease mean (SD), yr | 5.4 (6.0) | - | - |
Indexes | Mild activity, n = 29 | Moderate activity, n = 32 | Severe activity, n = 39 |
Serum vitamin D (ng/mL) | 14.8 ± 2.4 | 14.2 ± 2.4 | 11.7 ± 3.1 |
WBC (109/L) | 6.90 (4.53-12.81) | 7.13 (0.32-6.02) | 7.13 (3.28-17.59) |
CRP (mg/L) | 1.51 (0.38-66.23) | 9.90 (0.30-168.78) | 70.67 (1.44-190.07) |
ESR (mm/h) | 8 (3-34) | 23 (3-95) | 41 (7-127) |
ALP (U/L) | 81 (49-140) | 85 (40-602) | 77.50 (53-109) |
PLT (109/L) | 222 (113-363) | 260 (130-518) | 286 (125-500) |
HGB (g/L) | 137 (74-155) | 115 (59-164) | 115 (55-149) |
ALB (g/L) | 42.11 ± 4.97 | 37.25 ± 6.13 | 31.31 ± 4.79 |
Ca (mmol/L) | 2.31 (1.01-2.63) | 2.23 (1.67-2.49) | 2.06 (1.82-2.31) |
P (mmol/L) | 1.12 ± 0.20 | 1.17 ± 0.21 | 1.11 ± 0.27 |
Mayo score | 5 (3-5) | 8 (6-10) | 11.5 (11.0-12.0) |
- Citation: Wang HQ, Zhang WH, Wang YQ, Geng XP, Wang MW, Fan YY, Guan J, Shen JL, Chen X. Colonic vitamin D receptor expression is inversely associated with disease activity and jumonji domain-containing 3 in active ulcerative colitis. World J Gastroenterol 2020; 26(46): 7352-7366
- URL: https://www.wjgnet.com/1007-9327/full/v26/i46/7352.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i46.7352